Ratings by Rothschild Redburn (Issie Kirby)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2026 | Insulet Corporation | PODD | Downgrade | Neutral (Buy) |
193.62 (158.25) |
-18.27% | Details | |
| 3/4/2026 | Cooper Companies | COO | Downgrade | Neutral (Buy) |
83.92 (71.02) |
-15.37% | Details | |
| 2/3/2025 | DexCom | DXCM | Upgrade | Buy (Neutral) |
87.62 (70.14) |
-19.95% | Details | |
| 1/10/2025 | Alcon Inc. | ALC | Upgrade | Buy (N/A) |
83.71 (67.80) |
-19.01% | Details | |
| 5/30/2024 | Tandem Diabetes Care | TNDM | New Coverage | Buy (N/A) |
52.90 (16.24) |
-69.3% | Details | |
| 5/30/2024 | DexCom | DXCM | New Coverage | Neutral (N/A) |
127.38 (87.62) |
-31.21% | Details | |
| 5/30/2024 | Insulet Corporation | PODD | New Coverage | Buy (N/A) |
177.82 (193.62) |
8.89% | Details | |
| 3/19/2024 | Cooper Companies | COO | Upgrade | Buy (Neutral) |
100.71 (83.92) |
-16.67% | Details | |
| 10/5/2023 | Cooper Companies | COO | Downgrade | Neutral (Buy) |
312.91 (71.02) |
-77.3% | Details |
